Skip to main content
Clinical Trials/NCT06525454
NCT06525454CompletedNot Applicable

Feasibility and Acceptability of Individualized Automatic Target Coaching Message Based on the Metrics of Continuous Glucose Monitoring and Depressive Symptom

Samsung Medical Center1 site in 1 country18 target enrollmentStarted: August 7, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
18
Locations
1
Primary Endpoint
Time In Range

Study Overview

Brief Summary

This is a single-center, randomized, prospective, feasibility and acceptability trial in patients with type 1 diabetes. For six weeks, the intervention group will receive weekly personalized coaching messages for glycemic management based on blood data from continuous glucose monitors and bi-weekly personalized coaching messages for depression management based on depression questionnaires. The control group will remain on their current treatment and will not receive any intervention. The purpose of this trial is to evaluate the feasibility and acceptability of the clinical application of automated, personalized coaching messages for glycemic management and depressive symptom in people with type 1 diabetes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
20 Years to 69 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients who are determined to use continuous glucose monitoring based on their physician's medical judgment.
  • •Patients with type 1 diabetes, age 20-69 years old
  • •Currently receiving treatment with multiple insulin injection therapy
  • •Patients who have access to KakaoTalk via smartphone and are able to communicate with it
  • •Voluntarily agreed to participate in this clinical study.

Exclusion Criteria

  • •Subjects using oral hypoglycemic agents
  • •Steroid and immunosuppressant users
  • •Subjects receiving anticancer medications
  • •Breastfeeding or pregnant patients
  • •Patients who do not voluntarily consent to the study
  • •Anyone deemed unsuitable by the investigator to participate in the study

Arms & Interventions

Personalized coaching messages for glycemic management and depressive symptoms

Experimental

Intervention: Personalized coaching messages for blood glucose and emotions (Behavioral)

Treatment as usual

No Intervention

Outcomes

Primary Outcomes

Time In Range

Time Frame: Week 6

Derived from CGM

Secondary Outcomes

  • Time Below Range(Week 6)
  • Diabetes treatment satisfaction(Week 6)
  • Time In Tight Range(Week 6)
  • Glycemic Management Indicator(Week 6)
  • Depressive symptoms(Week 6)
  • Time Above Range(Week 6)
  • Coefficient of Variation(Week 6)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Gyuri Kim

Samsung Medical Centor

Samsung Medical Center

Study Sites (1)

Loading locations...

Similar Trials